+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
From
From
From
Anticoccidial Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Anticoccidial Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 162 Pages
  • Global
From
Swine Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Swine Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 398 Pages
  • Global
From
From
Poultry Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Poultry Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 602 Pages
  • Global
From
Companion Animal Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Companion Animal Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 478 Pages
  • Global
From
Brucellosis Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Brucellosis Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 276 Pages
  • Global
From
Combination Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Combination Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 373 Pages
  • Global
From
Live Attenuated Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Live Attenuated Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 563 Pages
  • Global
From
Ruminant Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Ruminant Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 563 Pages
  • Global
From
Pneumococcal Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Pneumococcal Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 285 Pages
  • Global
From
From
Cholera Vaccines - Global Strategic Business Report 2026 - Product Thumbnail Image

Cholera Vaccines - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 367 Pages
  • Global
From
HDAC Inhibitors Market 2023-2027 - Product Thumbnail Image

HDAC Inhibitors Market 2023-2027

  • Report
  • January 2023
  • 157 Pages
  • Global
From
HIV Clinical Trials Market - Global Forecast 2026-2032 - Product Thumbnail Image

HIV Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Male Hypogonadism - Global Strategic Business Report 2026 - Product Thumbnail Image

Male Hypogonadism - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 233 Pages
  • Global
From
Loading Indicator